Company news
Ondine Biomedical, Inc. news in 2022
Ondine Biomedical, Inc.'s news releases, calls and decks from 2022, newest first.
Appointment of Nominated Adviser
December 30, 2022
Steriwave receives regulatory approval in Mexico
December 12, 2022
Ondine receives funding for meat photodisinfection
December 5, 2022
Ondine reports full results from Phase 2 trial
December 2, 2022
Ondine appoints Spanish distributer for Steriwave
November 21, 2022
Food Processing Plant Sees Huge Reduction in Employee COVID-19 Rates After Using Ondine Biomedical’s Nasal Photodisinfection
November 8, 2022
Ondine cuts COVID-19 rate in food processing plant
November 7, 2022
PDMR Dealing
November 4, 2022
Ondine CTO receives Lifetime Achievement Award
October 31, 2022
Ondine presents new efficacy data against MRSA
October 19, 2022
Investor Presentation
October 11, 2022
Interim results for the six months to 30 June 2022
September 27, 2022
The Ottawa Hospital pilots nasal disinfection
September 23, 2022
New research presented on photodisinfection
September 20, 2022
Ondine's photodisinfection kills ESKAPE pathogens
September 7, 2022
Ondine reports successful US Phase 2 trial data
September 6, 2022
Nature reports Ondine therapy suppresses COVID-19
August 31, 2022
Ondine appoints RBC and Singer as joint brokers
August 16, 2022
Ondine completes US Phase II trial recruitment
August 8, 2022
Completion of Nominated Adviser due diligence
July 26, 2022
Ondine completes successful SARS-CoV-2 trial
July 19, 2022
Posting of annual report
June 7, 2022
Full Year Results to 31 December 2021
May 19, 2022
WHO calls for better infection prevention
May 10, 2022
Photodisinfection effective against SARS-CoV-2
April 5, 2022
Grant of Options and PDMR Dealing
February 21, 2022
Ondine treats first patients in Phase 2 FDA trial
February 7, 2022